[1]
Low, C.K. et al. 2023. PATIENTS’ QUALITY OF LIFE AFTER SWITCHING DESMOPRESSIN FROM TABLET TO SUBLINGUAL LYOPHILIZATE (MELT) FORMULATION: A SINGLE-CENTRE EXPERIENCE. Journal of the ASEAN Federation of Endocrine Societies. 38, S2 (Jul. 2023), 14. DOI:https://doi.org/10.15605/jafes.038.S2.14.